Emergence of Panton-Valentine leukocidin-positive ST59 methicillin-susceptible Staphylococcus aureus with high cytolytic peptide expression in association with community-acquired pediatric osteomyelitis complicated by pulmonary embolism

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 5, 2015, Pages 565-573

  Sawanobori, Emi ^a   Hung, Wei Chun ^b,c   Takano, Tomomi ^c   Hachuda, Koji ^a   Horiuchi, Tadahiro ^a   Higuchi, Wataru ^c   Hung, Wei Wen ^d   Iwao, Yasuhisa ^c,e   Nishiyama, Akihito ^c   Reva, Ivan ^c,e   Reva, Galina ^e   Teng, Lee Jene ^b   Yamamoto, Tatsuo ^c,e  

^a Kofu Municipal Hospital   (Japan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e International Medical Education and Research Center   (Japan)

Author keywords

Antibiotic treatment; Community associated methicillin susceptible Staphylococcus aureus (CA MSSA); Genotype; Pediatric osteomyelitis; Septic pulmonary embolism

Indexed keywords

BACTERIAL DNA; C REACTIVE PROTEIN; CEFAZOLIN; CHLORAMPHENICOL; CLINDAMYCIN; CLOXACILLIN; ERYTHROMYCIN; KANAMYCIN; MEROPENEM; METICILLIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS ENTEROTOXIN B; STREPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ADOLESCENT; ADOLESCENT DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CASE REPORT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE COURSE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMUR; FEVER; FURUNCULOSIS; GENE EXPRESSION; HOSPITAL ACQUIRED PNEUMONIA; HOUSEKEEPING GENE; HUMAN; HYPERTHERMIA; INSECT BITE; LUNG EMBOLISM; LUNG INFILTRATE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PAIN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUS; PYOMYOSITIS; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; SWELLING; THROMBOCYTE COUNT; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; DEBRIDEMENT; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOLECULAR TYPING; PULMONARY EMBOLISM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; DEBRIDEMENT; EXOTOXINS; GENOTYPE; HUMANS; LEUKOCIDINS; MALE; MOLECULAR TYPING; OSTEOMYELITIS; PULMONARY EMBOLISM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN;

EID: 84943582257     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.04.015     Document Type: Article

References (48)

1. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al. Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
2. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007, 13:1510-1514.
3. Diep B.A., Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 2008, 16:361-369.
4. Yamamoto T., Hung W.C., Takano T., Nishiyama A. Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus. BioMed 2013, 3:2-18.
5. Hung W.C., Takano T., Higuchi W., Iwao Y., Khokhlova O., Teng L.J., et al. Comparative genomics of community-acquired ST59 methicillin-resistant Staphylococcus aureus in Taiwan: novel mobile resistance structures with IS1216V. PLoS One 2012, 7:e46987.
6. Peltola H., Pääkkönen M. Acute osteomyelitis in children. N Engl J Med 2014, 370:352-360.
7. Gonzalez B.E., Teruya J., Mahoney D.H., Hulten K.G., Edwards R., Lamberth L.B., et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 2006, 117:1673-1679.
8. McCaskill M.L., Mason E.O., Kaplan S.L., Hammerman W., Lamberth L.B., Hultén K.G. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J 2007, 26:1122-1127.
9. The committee for The Japanese Respiratory Society guidelines in management of respiratory infections Antibacterial therapy of hospital-acquired pneumonia. Respirology 2004, 9:S16-S24.
10. Takano T., Higuchi W., Otsuka T., Baranovich T., Enany S., Saito K., et al. Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan. Antimicrob Agents Chemother 2008, 52:837-845.
11. Takano T., Hung W.C., Shibuya M., Higuchi W., Iwao Y., Nishiyama A., et al. A new local variant (ST764) of the globally disseminated ST5 lineage of hospital-associated methicillin-resistant Staphylococcus aureus (MRSA) carrying the virulence determinants of community-associated MRSA. Antimicrob Agents Chemother 2013, 57:1589-1595.
12. Higuchi W., Hung W.C., Takano T., Iwao Y., Ozaki K., Isobe H., et al. Molecular characteristics of the Taiwanese multiple drug-resistant ST59 clone of Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from pediatric cellulitis. J Infect Chemother 2010, 16:144-149.
13. van Wamel W.J., Rooijakkers S.H., Ruyken M., van Kessel K.P., van Strijp J.A. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 2006, 188:1310-1315.
14. Clinical and Laboratory Standards Institute Performance standard for antimicrobial susceptibility testing; 22nd informational supplement, M100-S22 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
15. Odds F.C. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003, 52:1.
16. Hung W.C., Mori H., Tsuji S., Iwao Y., Takano T., Nishiyama A., et al. Virulence gene and expression analysis of community-associated methicillin-resistant Staphylococcus aureus causing iliopsoas abscess and discitis with thrombocytopenia. J Infect Chemother 2013, 19:1004-1008.
17. Huang T.W., Chen F.J., Miu W.C., Liao T.L., Lin A.C., Huang I.W., et al. Complete genome sequence of Staphylococcus aureus M013, a pvl-positive, ST59-SCCmec type V strain isolated in Taiwan. J Bacteriol 2012, 194:1256-1257.
18. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC) Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009, 53:4961-4967.
19. Huang Y.C., Chen C.J. Community-associated methicillin-resistant Staphylococcus aureus in children in Taiwan, 2000s. Int J Antimicrob Agents 2011, 38:2-8.
20. Shibuya Y., Hara M., Higuchi W., Takano T., Iwao Y., Yamamoto T. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J Infect Chemother 2008, 14:439-441.
21. Higuchi W., Mimura S., Kurosawa Y., Takano T., Iwao Y., Yabe S., et al. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in a Japanese child, demonstrating multiple divergent strains in Japan. J Infect Chemother 2010, 16:292-297.
22. Takizawa Y., Taneike I., Nakagawa S., Oishi T., Nitahara Y., Iwakura N., et al. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 2005, 43:3356-3363.
23. Yamamoto T., Takano T., Higuchi W., Iwao Y., Singur O., Reva I., et al. Comparative genomics and drug resistance of a geographic variant of ST239 methicillin-resistant Staphylococcus aureus emerged in Russia. PLoS One 2012, 7:e29187.
24. T or SCCmec type IV. J Clin Microbiol 2005, 43:4719-4730.
25. Belthur M.V., Birchansky S.B., Verdugo A.A., Mason E.O., Hulten K.G., Kaplan S.L., et al. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am 2012, 94:34-42.
26. Gonzalez B.E., Hulten K.G., Dishop M.K., Lamberth L.B., Hammerman W.A., Mason E.O., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005, 41:583-590.
27. Chen C.J., Su L.H., Chiu C.H., Lin T.Y., Wong K.S., Chen Y.Y., et al. Clinical features and molecular characteristics of invasive community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Diagn Microbiol Infect Dis 2007, 59:287-293.
28. Wang J.L., Wang J.T., Chen S.Y., Chen Y.C., Chang S.C. Distribution of Staphylococcal cassette chromosome mec types and correlation with comorbidity and infection type in patients with MRSA bacteremia. PLoS One 2010, 5:e9489.
29. Grimbly C., Odenbach J., Vandermeer B., Forgie S., Curtis S. Parenteral and oral antibiotic duration for treatment of pediatric osteomyelitis: a systematic review protocol. Syst Rev 2013, 2:92.
30. Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011, 52:285-292.
31. Chen C.J., Chiu C.H., Lin T.Y., Lee Z.L., Yang W.E., Huang Y.C. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J 2007, 26:985-988.
32. Stevens D.L., Ma Y., Salmi D.B., McIndoo E., Wallace R.J., Bryant A.E. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 2007, 195:202-211.
33. Ritz N., Curtis N. The role of Panton-Valentine leukocidin in Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2012, 31:514-518.
34. Tsuchimochi N., Uchida Y., Nagasaki Y., Eriguchi Y., Maehara Y., Kagowaki M., et al. Combined antibacterial effects of between meropenem and vancomycin, teicoplanin, linezolid, or arbekacin in methicillin-resistant Staphylococcus aureus. Jpn J Chemother 2007, 55:363-367. [In Japanese, English abstract].
35. Higuchi W., Takano T., Teng L.J., Yamamoto T. Structure and specific detection of staphylococcal cassette chromosome mec type VII. Biochem Biophys Res Commun 2008, 377:752-756.
36. Wang C.C., Lo W.T., Chu M.L., Siu L.K. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004, 39:481-487.
37. Mahillon J., Chandler M. Insertion sequences. Microbiol Mol Biol Rev 1998, 62:725-774.
38. Périchon B., Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009, 53:4580-4587.
39. Sletvold H., Johnsen P.J., Wikmark O.G., Simonsen G.S., Sundsfjord A., Nielsen K.M. Tn1546 is part of a larger plasmid-encoded genetic unit horizontally disseminated among clonal Enterococcus faecium lineages. J Antimicrob Chemother 2010, 65:1894-1906.
40. Couppie P., Cribier B., Prévost G. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 1994, 130:1208-1209.
41. Lina G., Piémont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
42. Sina H., Ahoyo T.A., Moussaoui W., Keller D., Bankolé H.S., Barogui Y., et al. Variability of antibiotic susceptibility and toxin production of Staphylococcus aureus strains isolated from skin, soft tissue, and bone related infections. BMC Microbiol 2013, 13:188.
43. Crémieux A.C., Dumitrescu O., Lina G., Vallee C., Côté J.F., Muffat-Joly M., et al. Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One 2009, 4:e7204.
44. Jin T., Zhu Y.L., Li J., Shi J., He X.Q., Ding J., et al. Staphylococcal protein A, Panton-Valentine leukocidin and coagulase aggravate the bone loss and bone destruction in osteomyelitis. Cell Physiol Biochem 2013, 32:322-333.
45. Yamamoto T., Takano T., Yabe S., Higuchi W., Iwao Y., Isobe H., et al. Super-sticky familial infections caused by Panton-Valentine leukocidin-positive ST22 community-acquired methicillin-resistant Staphylococcus aureus in Japan. J Infect Chemother 2012, 18:187-198.
46. Hall M., Hoyt L., Ferrieri P., Schlievert P.M., Jenson H.B. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis 1999, 29:586-589.
47. Vojtov N., Ross H.F., Novick R. Global repression of exotoxin synthesis by staphylococcal superantigens. Proc Natl Acad Sci U S A 2002, 99:10102-10107.
48. Joo H.S., Cheung G.Y., Otto M. Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 2011, 286:8933-8940.